Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2022-06-29 Director's Dealing
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice 2 pages 147.9KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including the number and class of shares held, and notes the director's appointment date. This is a report of personal share transactions or holdings by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director share interests, with no financial statements or other report content. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-06-29 English
Board and Management Changes 1 page 183.0KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 8 June 2022 regarding changes in the company's board and management. It details the retirement of a director and appointments of new executive and assistant company secretaries. There is no financial data, report, or regulatory filing referenced beyond these personnel changes. The content clearly fits the category of announcements about changes in the company's board of directors or senior management.
2022-06-07 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 253.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'REPORT FOR THE QUARTER ENDED 31 MARCH 2022' and contains detailed financial and operational information for Bioxyne Limited for the quarter and nine months year-to-date. It includes unaudited sales revenue, cash flow statements, operational highlights, and compliance statements. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for entities listed on the ASX, confirms this is a quarterly financial report. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The content includes substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. Therefore, the appropriate classification is 'Interim / Quarterly Report' (IR). Q3 2022
2022-04-27 English
Change of Director's Interest Notice 2 pages 26.8KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including the number of shares held before and after the change, nature of the change, and dates. This type of document is a formal notification of personal share transactions by a company director. It does not contain financial performance data, management discussion, or other report content. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3603 characters, consistent with a detailed but concise insider transaction report.
2022-03-21 English
Appendix 4D and Interim Report 20 pages 571.8KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D – Half Year Report' and covers the half year ended 31 December 2021. It includes detailed financial statements such as the Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, Statement of Changes in Equity, and Notes to the Financial Statements. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document is approximately 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-02-21 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 233.7KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'REPORT FOR THE QUARTER ENDED 31 DECEMBER 2021' and contains detailed financial and operational information for Bioxyne Limited for the quarter and half year periods. It includes unaudited sales revenue, cash flow statements, and operational highlights. The presence of the Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed companies, confirms this is a quarterly financial report. The document is approximately 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2022
2022-01-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.